1 Global Mouth Ulcer Treatment Drug Market Size (Value) and CAGR (2024-2033)
In 2024, the global Mouth Ulcer Treatment Drug market was valued at USD 1432.04 million, with a CAGR of 3.5% from 2024 to 2033.
Mouth ulcer treatment drugs are pharmaceutical products designed to alleviate the symptoms and promote the healing of mouth ulcers. These ulcers, also known as canker sores or aphthous ulcers, are small, painful lesions that develop inside the mouth or at the base of the gums. They can be caused by various factors, including stress, injury, infection, and nutritional deficiencies. Mouth ulcer treatment drugs come in various forms, such as gels, sprays, patches, mouthwashes, and lozenges, each offering different benefits and mechanisms of action.
Figure Global Mouth Ulcer Treatment Drug Market Size (M USD) and CAGR 2024-2033
2 Mouth Ulcer Treatment Drug Market Drivers
The market for mouth ulcer treatment drugs is experiencing notable growth, driven by several key factors. One of the primary drivers is the increasing incidence of mouth ulcers, particularly among the geriatric population. As people age, they become more susceptible to oral health issues due to factors such as improper denture fittings, vitamin deficiencies, and weakened immune systems. This demographic trend is driving the demand for effective treatment options.
Another significant driver is the growing awareness about oral health. Governments and healthcare organizations worldwide are launching campaigns to educate the public about the importance of maintaining good oral hygiene. For instance, Colgate-Palmolive conducts annual oral health campaigns in rural areas of India, and Singapore’s Health Promotion Board collaborates with companies to promote oral health education. These initiatives are helping to increase consumer awareness and encouraging more people to seek treatment for mouth ulcers.
3 Mouth Ulcer Treatment Drug Market Restraints
Despite the growth drivers, the mouth ulcer treatment drug market faces several challenges and restraints. One significant challenge is the casual approach many people take towards mouth ulcers. Many individuals view these ulcers as minor and self-limiting, often neglecting treatment until symptoms become severe. This casual attitude can limit market growth, as a large portion of the population may not seek medical intervention for their oral health issues.
Another restraint is the availability of traditional treatments and the potential side effects of modern drugs. Some consumers prefer traditional remedies, which they perceive as safer and more natural. Additionally, modern mouth ulcer treatments can cause side effects such as headaches, blurred vision, and stomach pain, which may deter some patients from using these products.
4 Global Mouth Ulcer Treatment Drug Market Size by Type in 2024
Gels are the most prominent segment in the market, with a projected value of $542.46 million in 2024, accounting for 37.88% of the total market share. This popularity can be attributed to their quick-healing properties and ease of application. Gels form a protective barrier over the ulcer, reducing pain and promoting faster healing. They are particularly effective for treating ulcers on the inner cheeks, gums, and tongue, making them a versatile and widely-used option. Additionally, gels are available in various flavors and formulations, catering to both adults and children, which further enhances their market appeal.
Sprays follow closely behind, with a market value of $224.26 million and a share of 15.66% in 2024. Sprays are known for their convenience and ability to reach hard-to-access areas of the mouth. They often contain ingredients like benzocaine and lidocaine, which provide immediate pain relief. This non-invasive form of treatment is particularly beneficial for treating ulcers on the back of the throat and other areas that are difficult to reach with gels or patches. The ease of use and quick application make sprays a preferred choice for many consumers, especially those looking for a quick solution to their discomfort.
Patches represent a smaller but growing segment of the market, with a projected value of $73.03 million and a market share of 5.10% in 2024. Patches are adhesive strips that can be applied directly to the ulcer, providing localized treatment. They offer continuous relief and can stay in place for extended periods, making them a convenient option for consumers. Patches are particularly beneficial for treating ulcers that are difficult to reach with other forms of medication, as they provide targeted and sustained treatment.
Table Global Mouth Ulcer Treatment Drug Market Size by Type in 2024
Type | Market Size (M USD) 2024 |
Gel | 542.46 |
Spray | 224.26 |
Patch | 73.03 |
5 Global Mouth Ulcer Treatment Drug Market Size by Application in 2024
Online pharmacies are a rapidly growing segment, with a projected market value of $240.73 million in 2024, accounting for 16.81% of the total market share. The growth of online pharmacies can be attributed to the increasing convenience and accessibility they offer to consumers. During the COVID-19 pandemic, the shift towards online shopping accelerated, and many consumers discovered the benefits of purchasing healthcare products online. Online pharmacies provide a wide range of mouth ulcer treatment drugs, often at competitive prices, and offer the convenience of home delivery.
Drugstores remain the dominant application channel, with a projected market value of $1,191.31 million in 2024, accounting for 83.19% of the total market share. Drugstores offer consumers the opportunity to consult with pharmacists and receive immediate advice on the appropriate treatment for their mouth ulcers. The presence of a wide variety of treatment options, including over-the-counter and prescription drugs, makes drugstores a preferred choice for many consumers.
Table Global Mouth Ulcer Treatment Drug Market Size by Application in 2024
Application | Market Size (M USD) 2024 |
Online Pharmacy | 240.73 |
Drugstores | 1191.31 |
6 Global Mouth Ulcer Treatment Drug Market Size by Region in 2024
North America is the largest regional market, with a projected value of $505.54 million in 2024, accounting for 35.30% of the total market share. The region benefits from a well-developed healthcare infrastructure, high consumer awareness about oral health, and a strong presence of major pharmaceutical companies. The United States and Canada, in particular, have high per capita healthcare spending, which supports the demand for advanced and effective mouth ulcer treatment drugs.
Europe is the second-largest regional market, with a projected value of $481.74 million in 2024, accounting for 33.64% of the total market share. European countries have a strong focus on healthcare and oral hygiene, with governments and healthcare providers actively promoting awareness campaigns. The region is also home to several leading pharmaceutical companies that invest heavily in research and development.
The Asia-Pacific region is the fastest-growing market, with a projected value of $397.58 million in 2024, accounting for 27.76% of the total market share. The region’s growth is driven by a large and growing population, increasing awareness about oral health, and improving healthcare infrastructure. Countries like China, India, and Japan are particularly significant, with rising disposable incomes and a growing middle class that is more willing to spend on healthcare products.
Figure Global Mouth Ulcer Treatment Drug Market Size by Region in 2024
7 Major Players in Global Mouth Ulcer Treatment Drug Market
7.1 Church & Dwight
Company Profile: Church & Dwight, founded in 1846, is a world leader in household and personal care products. The company is headquartered in Ewing, New Jersey, USA, and operates globally. It is known for its diverse product portfolio, which includes well-known brands such as ARM & HAMMER®, Orajel, and Water Pik. Church & Dwight’s commitment to innovation and quality has solidified its position in the market.
Business Overview: Church & Dwight’s business spans a wide range of products, from oral care to household cleaning solutions. The company’s oral care products, such as Orajel™ Mouth Sore Gel, are specifically designed to provide relief from mouth ulcers and other oral discomforts. Orajel contains active ingredients like benzocaine and benzalkonium chloride, which offer immediate pain relief and antiseptic properties.
Product Offered: Orajel™ Mouth Sore Gel is one of Church & Dwight’s flagship products in the mouth ulcer treatment segment. It is formulated to provide quick relief from pain and promote healing. The product’s effectiveness and ease of use make it a popular choice among consumers.
Recent Financial Performance: In the most recent year, Church & Dwight reported a market value of $94.08 million for its mouth ulcer treatment drugs.
7.2 listerine (Johnson & Johnson)
Company Profile: listerine, a brand under Johnson & Johnson, is renowned for its antiseptic mouthwash products. Established in 1879, listerine has a long history of promoting oral hygiene and health. The brand is recognized globally for its effective formulations that help reduce plaque and prevent gum problems.
Business Overview: Johnson & Johnson, the parent company of listerine, is a multinational corporation with a diverse portfolio of healthcare products. listerine’s oral care products, such as LISTERINE® GUM CARE ZERO, are designed to provide comprehensive oral care, including relief from mouth ulcers. The product’s alcohol-free formula and essential oils make it suitable for daily use and effective in reducing oral bacteria.
Product Offered: LISTERINE® GUM CARE ZERO is a key product in the mouth ulcer treatment segment. It is formulated to provide relief from gum problems and mouth ulcers while maintaining overall oral health. The product’s non-alcoholic formula is gentle on the gums and provides long-lasting protection against oral issues.
Recent Financial Performance: In the most recent year, listerine reported a market value of $71.67 million for its mouth ulcer treatment drugs.
7.3 Pfizer
Company Profile: Pfizer, founded in 1848, is a global pharmaceutical company with a strong presence in the healthcare industry. Headquartered in New York, USA, Pfizer is known for its extensive portfolio of medicines, vaccines, and consumer healthcare products. The company’s commitment to innovation and research has led to the development of several groundbreaking treatments.
Business Overview: Pfizer’s business spans various therapeutic areas, including oncology, inflammation, and cardiovascular health. One of its notable products in the mouth ulcer treatment segment is Anbesol, which provides temporary relief from pain associated with mouth ulcers and other oral irritations. Anbesol contains benzocaine, an effective oral anesthetic that helps alleviate discomfort.
Product Offered: Anbesol is a key product in Pfizer’s mouth ulcer treatment portfolio. It is designed to provide quick relief from pain and promote healing. The product’s effectiveness and ease of use make it a popular choice among consumers seeking relief from oral discomfort.
Recent Financial Performance: In the most recent year, Pfizer reported a market value of $50.02 million for its mouth ulcer treatment drugs.